Mantle Biotech

United States
Primghar, Iowa, United States

Company profile

Mantle Biotech company profile

Mantle Biotech engineers binding proteins that can accurately identify disease biomarkers in patient samples, using directed evolution to modify heat-stable proteins produced by microbes. It allows the company to develop new diagnostic capabilities, producing high-quality binding proteins that are more stable and affordable than traditional reagents. This reagents can be adapted to a range of diseases and test formats, allowing the team to identify pain points throughout the broader diagnostic industry. Mantle Biotech was founded on 2019 and is headquartered in Cambridge, Massachusetts.

Business identity

Operating status
Closed
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0+
Founded
2019-01-01, Year

Headquarters

Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
3
Last funding
Non Equity Assistance / 2020-10-21
Last equity funding
Pre Seed
Investors
5
Lead investors
2
Founders
2

Founders and investors

Founders

Aditi TrehanEric Miller

Lead investors

MassChallengeMIT delta v

Investors

77MassChallengeMIT delta vPROTOCOL — by GETTYLABSBXi